A Study of ARRY-371797 in Patients With Active Ankylosing Spondylitis

NCT00811499 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

DRUG: ARRY-371797, p38 inhibitor; oral
DRUG: Placebo; oral
DRUG: Placebo; oral

Sponsor

Pfizer